Log In
BCIQ
Print this Print this
 

CyclASol

  Manage Alerts
Collapse Summary General Information
Company Novaliq GmbH
DescriptionClear cyclosporin solution developed using Novaliq's EyeSol semi-fluorinated alkane (SFA) drug delivery platform
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacrocycle
Latest Stage of DevelopmentPhase II
Standard IndicationDry eye
Indication DetailsTreat dry eye syndrome
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today